CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • August 16th, 2021 • Athira Pharma, Inc. • Biological products, (no disgnostic substances) • Washington
This Change in Control and Severance Agreement (the “Agreement”) is made by and between Athira Pharma, Inc., a Delaware corporation (the “Company”), and Rachel Lenington (“Executive”), effective as of June 14, 2021 (the “Effective Date”).
FIRST AMENDMENT TO LEASELease • August 16th, 2021 • Athira Pharma, Inc. • Biological products, (no disgnostic substances)
This First Amendment to Lease (this “First Amendment”) is dated as of June 28, 2021, and is by and between NITROGEN PROPCO 2020, L.P., a Delaware limited partnership (“Landlord”), and ATHIRA PHARMA, INC., a Delaware corporation (“Tenant”).
18706 North Creek Parkway Suite 104 Bothell, Washington 98011Offer Letter • August 16th, 2021 • Athira Pharma, Inc. • Biological products, (no disgnostic substances)
